0
ARTICLE |

Percutaneous Transhepatic Cholangiography and Cinecholangiography

Richard N. Myers, MD; J. Montgomery Deaver, MD; George J. Haupt, MD; Newton C. Birkhead, MD, PhD
Arch Surg. 1968;97(1):51-55. doi:10.1001/archsurg.1968.01340010081007.
Text Size: A A A
Published online

PERCUTANEOUS transhepatic cholangiography is well established as a valuable adjunct in the differential diagnosis of the jaundiced patient. It is also valuable in determining partially obstructive factors in the nonjaundiced patient with poor liver function. To the surgeon, the preoperative recognition of the location, nature, and extent of biliary tract abnormalities is invaluable in planning the operative procedure more precisely. Cinecholangiography added to percutaneous transhepatic cholangiography increases the information obtained from the procedure. Cinefluorography provides continuous observation during gradual filling of the biliary system, with any pathologic derangements dynamically demonstrated.

Percutaneous transhepatic cholangiography was first described in 1921 by Burkhardt and Muller1 in Germany, and again in 1937 by Huard and Do-Xuan-Hop in France.2 The first reported experience with percutaneous cholangiography in the United States was that of Carter and Saypol3 in 1952. Since then many reports have attested to the value of this technique. The addition

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs